Medicine and Dentistry
Venous Thromboembolism
95%
Pulmonary Embolism
69%
Pulmonary Hypertension
55%
Major Bleeding
47%
Anticoagulation
38%
Acute Pulmonary Embolism
36%
Chronic Thromboembolic Pulmonary Hypertension
33%
Deep Vein Thrombosis
31%
Recurrent Disease
31%
Anticoagulant Therapy
30%
Bleeding
15%
Hazard Ratio
13%
COVID-19
13%
Combination Therapy
12%
Thrombosis
11%
Meldonium
10%
Comorbidity
10%
Odds Ratio
10%
Direct Oral Anticoagulant
9%
Vitamin K Antagonist
8%
All Cause Mortality
8%
Hemodynamic
8%
Atrial Fibrillation
7%
Cohort Analysis
7%
Risk Stratification
7%
Thrombophilia
7%
Upper Limb
7%
Thromboembolism
7%
Angioplasty
7%
Persistent Truncus Arteriosus
7%
Upper Extremity Deep Vein Thrombosis
7%
Thrombus
7%
Lung Vascular Resistance
6%
Systolic Blood Pressure
6%
Low Molecular Weight Heparin
6%
Lung Cancer
6%
Anemia
5%
Echocardiography
5%
Right Ventricle
5%
Platelet
5%
Brain Natriuretic Peptide
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Pulmonary Hypertension
61%
Lung Embolism
56%
Bleeding
42%
Recurrent Disease
30%
Anticoagulant Agent
28%
Deep Vein Thrombosis
22%
Chronic Thromboembolic Pulmonary Hypertension
19%
Combination Therapy
15%
Direct Oral Anticoagulant
12%
Comorbidity
12%
Antivitamin K
10%
Meldonium
10%
Low Molecular Weight Heparin
8%
Thrombophilia
8%
Cohort Study
7%
Lung Cancer
7%
Congenital Heart Disease
7%
Rodatristat Ethyl
7%
Statin (Protein)
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Brain Natriuretic Peptide
6%
Recurrence Risk
6%
Chronic Kidney Failure
5%
All Cause Mortality
5%
Nursing and Health Professions
Venous Thromboembolism
28%
Bleeding
23%
Lung Embolism
15%
Pulmonary Hypertension
14%
Anticoagulation
13%
Anticoagulant Therapy
12%
Recurrent Disease
11%
Upper Extremity Deep Vein Thrombosis
10%
Antivitamin K
10%
Deep Vein Thrombosis
10%
Thrombosis
7%
Dabigatran
7%
Cerebrovascular Accident
7%
Clinical Outcome
7%
Odds Ratio
7%
Confidence Interval
6%
Retinol
5%
